Relapsed/Refractory Chronic Lymphocytic Leukemia
6 clinical trials · Condition
◉ Watch Relapsed/Refractory Chronic Lymphocytic Leukemia
| Record | Firm | Date |
|---|---|---|
| Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL (NCT03708003) | Swiss Cancer Institute | 2019-03-11 |
| Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant (NCT00697684) | Beth Israel Deaconess Medical Center | 2008-06-01 |
| Expanded Access Program for Participants Who Completed Study 13-601 and Continue to Clinically Benefit From Cerdulatinib (NCT04757259) | Alexion Pharmaceuticals, Inc. |
Track Relapsed/Refractory Chronic Lymphocytic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.